Food and Drug
Administration
Vaccines
and Related Biological Products Advisory Committee
May 18, 2006
Slides:
GARDASIL®Quadrivalent HPV (Types 6, 11,
16, 18) L1 VLP Vaccine, Merck Research Laboratories (ppt)
(htm)
GardasilTM : Quadrivalent Human Papillomavirus
6, 11, 16, 18 L1 VLP Vaccine, Applicant: Merck & Co.,
Inc., Nancy B. Miller, M.D., CBER, FDA (ppt)
(htm)
Open Public Comments:
Society of Gynecologic Oncologists (pdf)
Coalition of Labor Union Women (pdf)
Association of Reproductive Health Professionals
(pdf)
American Society for Reproductive Medicine
(pdf)
Society for Women’s Health Research
(pdf)
Women In Government (pdf)
National Coalition for Cancer Survivorship
(pdf)
American Social Health Association (pdf)
National Coalition of STD Directors (pdf)
Individual Public Comment (pdf)
American Medical Women's Association (pdf)
Individual Public Comment (pdf)
Individual Public Comment (pdf)
Up
| AC Home Page